Ascendis Pharma Welcomes You to ESPE Conference 2022

Ascendis Pharma Welcomes You to ESPE Conference 2022


Ascendis Pharma was founded in 2007 to leverage the innovative TransCon® technology platform to make a meaningful difference for patients.

We are a dynamic, growing biopharma company with offices in Denmark, Germany and the United States. We’re advancing programs and product candidates in both endocrinology rare diseases and in oncology.

Our commitment to patients is reflected in our mission and core values of patients, science, and passion.



Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we use our TransCon® technology to fulfill our mission of developing new and potentially best-in-class therapies that address unmet medical needs.